ID   L2HDH_HUMAN             Reviewed;         463 AA.
AC   Q9H9P8; Q9BRR1;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   28-JUN-2023, entry version 163.
DE   RecName: Full=L-2-hydroxyglutarate dehydrogenase, mitochondrial;
DE            EC=1.1.99.2;
DE   AltName: Full=Duranin;
DE   Flags: Precursor;
GN   Name=L2HGDH; Synonyms=C14orf160;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS L2HGA GLU-81 AND ASP-176,
RP   AND CHARACTERIZATION OF VARIANTS L2HGA GLU-81 AND ASP-176.
RX   PubMed=15548604; DOI=10.1073/pnas.0404840101;
RA   Rzem R., Veiga-da-Cunha M., Noel G., Goffette S., Nassogne M.-C.,
RA   Tabarki B., Schoeller C., Marquardt T., Vikkula M., van Schaftingen E.;
RT   "A gene encoding a putative FAD-dependent L-2-hydroxyglutarate
RT   dehydrogenase is mutated in L-2-hydroxyglutaric aciduria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:16849-16854(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ARG-18.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION,
RP   AND COFACTOR.
RX   PubMed=16005139; DOI=10.1016/j.biochi.2005.06.005;
RA   Rzem R., Van Schaftingen E., Veiga-da-Cunha M.;
RT   "The gene mutated in L-2-hydroxyglutaric aciduria encodes L-2-
RT   hydroxyglutarate dehydrogenase.";
RL   Biochimie 88:113-116(2006).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-155, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANTS L2HGA ASP-55; TYR-98 AND LEU-302, AND TISSUE SPECIFICITY.
RX   PubMed=15385440; DOI=10.1093/hmg/ddh300;
RA   Topcu M., Jobard F., Halliez S., Coskun T., Yalcinkayal C., Gerceker F.O.,
RA   Wanders R.J.A., Prud'homme J.-F., Lathrop M., Ozguc M., Fischer J.;
RT   "L-2-hydroxyglutaric aciduria: identification of a mutant gene C14orf160,
RT   localized on chromosome 14q22.1.";
RL   Hum. Mol. Genet. 13:2803-2811(2004).
RN   [11]
RP   VARIANTS L2HGA ARG-57; ARG-98; LEU-302 AND PRO-434, AND VARIANTS ARG-18 AND
RP   PHE-178.
RX   PubMed=16134148; DOI=10.1002/humu.9373;
RA   Vilarinho L., Cardoso M.L., Gaspar P., Barbot C., Azevedo L., Diogo L.,
RA   Santos M., Carrilho I., Fineza I., Kok F., Chorao R., Alegria P.,
RA   Martins E., Teixeira J., Cabral-Fernandes H., Verhoeven N.M.,
RA   Salomons G.S., Santorelli F.M., Cabral P., Amorim A., Jakobs C.;
RT   "Novel L2HGDH mutations in 21 patients with L-2-hydroxyglutaric aciduria of
RT   Portuguese origin.";
RL   Hum. Mutat. 26:395-396(2005).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-2-hydroxyglutarate + A = 2-oxoglutarate + AH2;
CC         Xref=Rhea:RHEA:21252, ChEBI:CHEBI:13193, ChEBI:CHEBI:16782,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:17499; EC=1.1.99.2;
CC         Evidence={ECO:0000269|PubMed:16005139};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:16005139};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=800 uM for L-2-hydroxyglutarate {ECO:0000269|PubMed:16005139};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16005139}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H9P8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H9P8-2; Sequence=VSP_017662, VSP_017663;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in brain, testis
CC       and muscle. Expressed to a lower extent in lymphocytes, fibroblasts,
CC       keratinocytes, placenta, bladder, small intestine, liver and bone
CC       marrow. {ECO:0000269|PubMed:15385440}.
CC   -!- DISEASE: L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792]: A rare
CC       autosomal recessive disorder clinically characterized by mild
CC       psychomotor delay in the first years of life, followed by progressive
CC       cerebellar ataxia, dysarthria and moderate to severe intellectual
CC       disability. Diagnosis is based on the presence of an excess of L-2-
CC       hydroxyglutaric acid in urine, blood and cerebrospinal fluid.
CC       {ECO:0000269|PubMed:15385440, ECO:0000269|PubMed:15548604,
CC       ECO:0000269|PubMed:16134148}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Was named 'duranin' in honor of Marinus Duran, who first
CC       described L-2-hydroxyglutaric aciduria.
CC   -!- SIMILARITY: Belongs to the L2HGDH family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY757363; AAV52330.1; -; mRNA.
DR   EMBL; AK022680; BAB14174.1; -; mRNA.
DR   EMBL; AL109758; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006117; AAH06117.1; -; mRNA.
DR   CCDS; CCDS9698.1; -. [Q9H9P8-1]
DR   RefSeq; NP_079160.1; NM_024884.2. [Q9H9P8-1]
DR   RefSeq; XP_005268132.1; XM_005268075.4. [Q9H9P8-1]
DR   AlphaFoldDB; Q9H9P8; -.
DR   SMR; Q9H9P8; -.
DR   BioGRID; 123016; 78.
DR   IntAct; Q9H9P8; 18.
DR   STRING; 9606.ENSP00000267436; -.
DR   GlyGen; Q9H9P8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H9P8; -.
DR   PhosphoSitePlus; Q9H9P8; -.
DR   SwissPalm; Q9H9P8; -.
DR   BioMuta; L2HGDH; -.
DR   DMDM; 317373422; -.
DR   EPD; Q9H9P8; -.
DR   jPOST; Q9H9P8; -.
DR   MassIVE; Q9H9P8; -.
DR   MaxQB; Q9H9P8; -.
DR   PaxDb; Q9H9P8; -.
DR   PeptideAtlas; Q9H9P8; -.
DR   ProteomicsDB; 81345; -. [Q9H9P8-1]
DR   ProteomicsDB; 81346; -. [Q9H9P8-2]
DR   Antibodypedia; 47264; 201 antibodies from 26 providers.
DR   DNASU; 79944; -.
DR   Ensembl; ENST00000267436.9; ENSP00000267436.4; ENSG00000087299.12. [Q9H9P8-1]
DR   Ensembl; ENST00000421284.7; ENSP00000405559.3; ENSG00000087299.12. [Q9H9P8-1]
DR   GeneID; 79944; -.
DR   KEGG; hsa:79944; -.
DR   MANE-Select; ENST00000267436.9; ENSP00000267436.4; NM_024884.3; NP_079160.1.
DR   UCSC; uc001wxu.4; human. [Q9H9P8-1]
DR   AGR; HGNC:20499; -.
DR   CTD; 79944; -.
DR   DisGeNET; 79944; -.
DR   GeneCards; L2HGDH; -.
DR   HGNC; HGNC:20499; L2HGDH.
DR   HPA; ENSG00000087299; Low tissue specificity.
DR   MalaCards; L2HGDH; -.
DR   MIM; 236792; phenotype.
DR   MIM; 609584; gene.
DR   neXtProt; NX_Q9H9P8; -.
DR   OpenTargets; ENSG00000087299; -.
DR   Orphanet; 79314; L-2-hydroxyglutaric aciduria.
DR   PharmGKB; PA134971279; -.
DR   VEuPathDB; HostDB:ENSG00000087299; -.
DR   eggNOG; KOG2665; Eukaryota.
DR   GeneTree; ENSGT00490000043421; -.
DR   HOGENOM; CLU_024775_0_0_1; -.
DR   InParanoid; Q9H9P8; -.
DR   OMA; GVHFTRM; -.
DR   OrthoDB; 1815533at2759; -.
DR   PhylomeDB; Q9H9P8; -.
DR   TreeFam; TF105922; -.
DR   BRENDA; 1.1.99.2; 2681.
DR   PathwayCommons; Q9H9P8; -.
DR   Reactome; R-HSA-880009; Interconversion of 2-oxoglutarate and 2-hydroxyglutarate.
DR   SABIO-RK; Q9H9P8; -.
DR   SignaLink; Q9H9P8; -.
DR   BioGRID-ORCS; 79944; 14 hits in 1160 CRISPR screens.
DR   ChiTaRS; L2HGDH; human.
DR   GeneWiki; L2HGDH; -.
DR   GenomeRNAi; 79944; -.
DR   Pharos; Q9H9P8; Tbio.
DR   PRO; PR:Q9H9P8; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9H9P8; protein.
DR   Bgee; ENSG00000087299; Expressed in muscle of leg and 137 other tissues.
DR   ExpressionAtlas; Q9H9P8; baseline and differential.
DR   Genevisible; Q9H9P8; HS.
DR   GO; GO:0016020; C:membrane; IDA:HGNC-UCL.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HGNC-UCL.
DR   GO; GO:0047545; F:2-hydroxyglutarate dehydrogenase activity; IDA:HGNC-UCL.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; IDA:HGNC-UCL.
DR   Gene3D; 3.30.9.10; D-Amino Acid Oxidase, subunit A, domain 2; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   PANTHER; PTHR43104; L-2-HYDROXYGLUTARATE DEHYDROGENASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43104:SF2; L-2-HYDROXYGLUTARATE DEHYDROGENASE, MITOCHONDRIAL; 1.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Disease variant; FAD; Flavoprotein;
KW   Mitochondrion; Oxidoreductase; Reference proteome; Transit peptide.
FT   TRANSIT         1..51
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           52..463
FT                   /note="L-2-hydroxyglutarate dehydrogenase, mitochondrial"
FT                   /id="PRO_0000228129"
FT   MOD_RES         104
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YP0"
FT   MOD_RES         155
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         173
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YP0"
FT   VAR_SEQ         400
FT                   /note="G -> QVAVRGPSWLWQQPMKVSDNNIYCFLWRCFALLLTGSTCSFK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017662"
FT   VAR_SEQ         401..463
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017663"
FT   VARIANT         18
FT                   /note="L -> R (in dbSNP:rs2275591)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025681"
FT   VARIANT         33
FT                   /note="R -> S (in dbSNP:rs35710558)"
FT                   /id="VAR_057808"
FT   VARIANT         55
FT                   /note="G -> D (in L2HGA; dbSNP:rs118204021)"
FT                   /evidence="ECO:0000269|PubMed:15385440"
FT                   /id="VAR_025682"
FT   VARIANT         57
FT                   /note="G -> R (in L2HGA; dbSNP:rs199690954)"
FT                   /evidence="ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025683"
FT   VARIANT         81
FT                   /note="K -> E (in L2HGA; alters protein processing and
FT                   abolishes catalytic activity; dbSNP:rs970541687)"
FT                   /evidence="ECO:0000269|PubMed:15548604"
FT                   /id="VAR_025684"
FT   VARIANT         98
FT                   /note="H -> R (in L2HGA; dbSNP:rs267607206)"
FT                   /evidence="ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025685"
FT   VARIANT         98
FT                   /note="H -> Y (in L2HGA)"
FT                   /evidence="ECO:0000269|PubMed:15385440"
FT                   /id="VAR_025686"
FT   VARIANT         176
FT                   /note="E -> D (in L2HGA; alters protein processing and
FT                   abolishes catalytic activity)"
FT                   /evidence="ECO:0000269|PubMed:15548604"
FT                   /id="VAR_025687"
FT   VARIANT         178
FT                   /note="Y -> F (in dbSNP:rs770542189)"
FT                   /evidence="ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025688"
FT   VARIANT         302
FT                   /note="P -> L (in L2HGA; dbSNP:rs118204020)"
FT                   /evidence="ECO:0000269|PubMed:15385440,
FT                   ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025689"
FT   VARIANT         434
FT                   /note="H -> P (in L2HGA; dbSNP:rs750044734)"
FT                   /evidence="ECO:0000269|PubMed:16134148"
FT                   /id="VAR_025690"
SQ   SEQUENCE   463 AA;  50316 MW;  1B6BC0C88543B7FF CRC64;
     MVPALRYLVG ACGRARGLFA GGSPGACGFA SGRPRPLCGG SRSASTSSFD IVIVGGGIVG
     LASARALILR HPSLSIGVLE KEKDLAVHQT GHNSGVIHSG IYYKPESLKA KLCVQGAALL
     YEYCQQKGIS YKQCGKLIVA VEQEEIPRLQ ALYEKGLQNG VPGLRLIQQE DIKKKEPYCR
     GLMAIDCPHT GIVDYRQVAL SFAQDFQEAG GSVLTNFEVK GIEMAKESPS RSIDGMQYPI
     VIKNTKGEEI RCQYVVTCAG LYSDRISELS GCTPDPRIVP FRGDYLLLKP EKCYLVKGNI
     YPVPDSRFPF LGVHFTPRMD GSIWLGPNAV LAFKREGYRP FDFSATDVMD IIINSGLIKL
     ASQNFSYGVT EMYKACFLGA TVKYLQKFIP EITISDILRG PAGVRAQALD RDGNLVEDFV
     FDAGVGDIGN RILHVRNAPS PAATSSIAIS GMIADEVQQR FEL
//
